Name: Latest research reports of Biocon Ltd. authored by Sharekhan and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: Sharekhan

Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer

336.4000 2.60 (0.78%)

NSE Apr 23, 2025 13:17 PM

Volume: 1.5M

Biocon Ltd.

12 Nov 2024

336.40

0.78%

Soft quarter, expect recovery in H2

Buy: Biocon Ltd.

Sharekhan

Revenues stood at Rs. 3,590 crore, up 4% y-o-y and a 5% rise q-o-q. EBITDA reached Rs. 730 crore, down 1% y-o-y but up 24% q-o-q. PAT stood at Rs. 27 crore, a decline of 84% y-o-y and 97% q-o-q.

Biocon Ltd. is trading above its 30 day SMA of 333.0